市場調査レポート
商品コード
1384553

牛用治療システムの世界市場、2024~2028年

Global Bovine Treatment System Market 2024-2028

出版日: | 発行: TechNavio | ページ情報: 英文 161 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
牛用治療システムの世界市場、2024~2028年
出版日: 2023年11月09日
発行: TechNavio
ページ情報: 英文 161 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

牛用治療システム市場は2023~2028年に38億1,954万米ドル、予測期間中のCAGRは5.51%で成長すると予測されます。

当レポートでは、牛用治療システム市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、畜産業の成長、動物福祉への関心、持続可能な有機農法への関心の高まりによって牽引されています。

市場範囲
基準年 2023年
終了年 2028年
予測期間 2024~2028年
成長モメンタム 加速
前年比2024年 4.88%
CAGR 5.51%
増分額 38億1,954万米ドル

本調査では、今後数年間の牛用治療システム市場成長を牽引する主な要因の1つとして、疾病管理への注目の高まりを挙げています。また、予防医療への関心の高まりと治療法の技術的進歩が市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模の把握

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023年
  • 市場の展望 2023~2028年

第4章 市場規模実績

  • 牛用治療システムの世界市場 2018~2022年
  • タイプ別セグメント分析 2018~2022年
  • エンドユーザー別セグメント分析 2018~2022年
  • 地域別セグメント分析 2018~2022年
  • 国別セグメント分析 2018~2022年

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:タイプ別

  • 市場セグメント
  • 比較:タイプ別
  • 医薬品および生物製剤:市場規模と予測 2023~2028年
  • 栄養補助食品:市場規模と予測 2023~2028年
  • 管理システム:市場規模と予測 2023~2028年
  • 市場機会:タイプ別

第7章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 酪農場:市場規模と予測 2023~2028年
  • 動物病院とクリニック:市場規模と予測 2023~2028年
  • 牛肉用牧場:市場規模と予測 2023~2028年
  • 市場機会:エンドユーザー別

第8章 顧客情勢

  • 顧客情勢概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023~2028年
  • 欧州:市場規模と予測 2023~2028年
  • アジア:市場規模と予測 2023~2028年
  • 世界のその他の中東・アフリカ:市場規模と予測 2023~2028年
  • 米国:市場規模と予測 2023~2028年
  • ドイツ:市場規模と予測 2023~2028年
  • 英国:市場規模と予測 2023~2028年
  • 中国:市場規模と予測 2023~2028年
  • フランス:市場規模と予測 2023~2028年
  • 市場機会:地域情勢別

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Advanced Animal Diagnostics
  • Bio-Vet
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Inc.
  • Endovac Animal Health
  • HIPRA S A
  • ImmuCell Corp.
  • Merck KGaA
  • Nimrod Veterinary Products Ltd.
  • Norbrook Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Vetoquinol SA
  • Virbac Group
  • Zoetis Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global bovine treatment system market 2018 - 2022 ($ million)
  • Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Type - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Type
  • Exhibits33: Data Table on Comparison by Type
  • Exhibits34: Chart on Pharmaceutical and biologicals - Market size and forecast 2023-2028 ($ million)
  • Exhibits35: Data Table on Pharmaceutical and biologicals - Market size and forecast 2023-2028 ($ million)
  • Exhibits36: Chart on Pharmaceutical and biologicals - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Pharmaceutical and biologicals - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Nutritional supplements - Market size and forecast 2023-2028 ($ million)
  • Exhibits39: Data Table on Nutritional supplements - Market size and forecast 2023-2028 ($ million)
  • Exhibits40: Chart on Nutritional supplements - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Nutritional supplements - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Management system - Market size and forecast 2023-2028 ($ million)
  • Exhibits43: Data Table on Management system - Market size and forecast 2023-2028 ($ million)
  • Exhibits44: Chart on Management system - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Management system - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Market opportunity by Type ($ million)
  • Exhibits47: Data Table on Market opportunity by Type ($ million)
  • Exhibits48: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits50: Chart on Comparison by End-user
  • Exhibits51: Data Table on Comparison by End-user
  • Exhibits52: Chart on Dairy farm - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on Dairy farm - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on Dairy farm - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Dairy farm - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Veterinary hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibits57: Data Table on Veterinary hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibits58: Chart on Veterinary hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Veterinary hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Chart on Beef farm - Market size and forecast 2023-2028 ($ million)
  • Exhibits61: Data Table on Beef farm - Market size and forecast 2023-2028 ($ million)
  • Exhibits62: Chart on Beef farm - Year-over-year growth 2023-2028 (%)
  • Exhibits63: Data Table on Beef farm - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Market opportunity by End-user ($ million)
  • Exhibits65: Data Table on Market opportunity by End-user ($ million)
  • Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits69: Chart on Geographic comparison
  • Exhibits70: Data Table on Geographic comparison
  • Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits107: Market opportunity By Geographical Landscape ($ million)
  • Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits109: Impact of drivers and challenges in 2023 and 2028
  • Exhibits110: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits111: Overview on factors of disruption
  • Exhibits112: Impact of key risks on business
  • Exhibits113: Vendors covered
  • Exhibits114: Matrix on vendor position and classification
  • Exhibits115: Advanced Animal Diagnostics - Overview
  • Exhibits116: Advanced Animal Diagnostics - Product / Service
  • Exhibits117: Advanced Animal Diagnostics - Key offerings
  • Exhibits118: Bio-Vet - Overview
  • Exhibits119: Bio-Vet - Product / Service
  • Exhibits120: Bio-Vet - Key offerings
  • Exhibits121: Boehringer Ingelheim International GmbH - Overview
  • Exhibits122: Boehringer Ingelheim International GmbH - Business segments
  • Exhibits123: Boehringer Ingelheim International GmbH - Key news
  • Exhibits124: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibits125: Boehringer Ingelheim International GmbH - Segment focus
  • Exhibits126: Ceva Sante Animale - Overview
  • Exhibits127: Ceva Sante Animale - Product / Service
  • Exhibits128: Ceva Sante Animale - Key offerings
  • Exhibits129: Elanco Animal Health Inc. - Overview
  • Exhibits130: Elanco Animal Health Inc. - Product / Service
  • Exhibits131: Elanco Animal Health Inc. - Key offerings
  • Exhibits132: Endovac Animal Health - Overview
  • Exhibits133: Endovac Animal Health - Product / Service
  • Exhibits134: Endovac Animal Health - Key offerings
  • Exhibits135: HIPRA S A - Overview
  • Exhibits136: HIPRA S A - Product / Service
  • Exhibits137: HIPRA S A - Key offerings
  • Exhibits138: ImmuCell Corp. - Overview
  • Exhibits139: ImmuCell Corp. - Business segments
  • Exhibits140: ImmuCell Corp. - Key offerings
  • Exhibits141: ImmuCell Corp. - Segment focus
  • Exhibits142: Merck KGaA - Overview
  • Exhibits143: Merck KGaA - Business segments
  • Exhibits144: Merck KGaA - Key news
  • Exhibits145: Merck KGaA - Key offerings
  • Exhibits146: Merck KGaA - Segment focus
  • Exhibits147: Nimrod Veterinary Products Ltd. - Overview
  • Exhibits148: Nimrod Veterinary Products Ltd. - Product / Service
  • Exhibits149: Nimrod Veterinary Products Ltd. - Key offerings
  • Exhibits150: Norbrook Laboratories Ltd. - Overview
  • Exhibits151: Norbrook Laboratories Ltd. - Product / Service
  • Exhibits152: Norbrook Laboratories Ltd. - Key offerings
  • Exhibits153: Thermo Fisher Scientific Inc. - Overview
  • Exhibits154: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits155: Thermo Fisher Scientific Inc. - Key news
  • Exhibits156: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits157: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits158: Vetoquinol SA - Overview
  • Exhibits159: Vetoquinol SA - Business segments
  • Exhibits160: Vetoquinol SA - Key news
  • Exhibits161: Vetoquinol SA - Key offerings
  • Exhibits162: Vetoquinol SA - Segment focus
  • Exhibits163: Virbac Group - Overview
  • Exhibits164: Virbac Group - Business segments
  • Exhibits165: Virbac Group - Key news
  • Exhibits166: Virbac Group - Key offerings
  • Exhibits167: Virbac Group - Segment focus
  • Exhibits168: Zoetis Inc. - Overview
  • Exhibits169: Zoetis Inc. - Business segments
  • Exhibits170: Zoetis Inc. - Key news
  • Exhibits171: Zoetis Inc. - Key offerings
  • Exhibits172: Zoetis Inc. - Segment focus
  • Exhibits173: Inclusions checklist
  • Exhibits174: Exclusions checklist
  • Exhibits175: Currency conversion rates for US$
  • Exhibits176: Research methodology
  • Exhibits177: Validation techniques employed for market sizing
  • Exhibits178: Information sources
  • Exhibits179: List of abbreviations
目次
Product Code: IRTNTR76786

Abstract

The bovine treatment system market is forecasted to grow by USD 3,819.54 mn during 2023-2028, accelerating at a CAGR of 5.51% during the forecast period. The report on the bovine treatment system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by livestock industry growth, animal welfare concerns, and growing interest in sustainable and organic farming practices.

Market Scope
Base Year2023
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20244.88%
CAGR5.51%
Incremental Value$3819.54mn

Technavio's bovine treatment system market is segmented as below:

By Type

  • Pharmaceutical and biologicals
  • Nutritional supplements
  • Management system

By End-user

  • Dairy farm
  • Veterinary hospitals and clinics
  • Beef farm

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increased focus on disease management as one of the prime reasons driving the bovine treatment system market growth during the next few years. Also, growing adoption of preventive care and technological advances in treatment method will lead to sizable demand in the market.

The report on the bovine treatment system market covers the following areas:

  • Bovine treatment system market sizing
  • Bovine treatment system market forecast
  • Bovine treatment system market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bovine treatment system market vendors that include Advanced Animal Diagnostics, Armenta, Bio-Vet, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., Endovac Animal Health, Forte Healthcare Ltd., Huvepharma EOOD, ImmuCell Corp., Merck KGaA, Neogen Corp., Nimrod Veterinary Products Ltd., Norbrook Laboratories Ltd., Thermo Fisher Scientific Inc., Vetoquinol SA, Virbac Group, West Way Health, Zoetis Inc., and HIPRA S A. Also, the bovine treatment system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global bovine treatment system market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global bovine treatment system market 2018 - 2022 ($ million)
  • 4.2 Type Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.3 End-user Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

  • 6.1 Market segments
  • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
  • 6.2 Comparison by Type
  • Exhibit 32: Chart on Comparison by Type
  • Exhibit 33: Data Table on Comparison by Type
  • 6.3 Pharmaceutical and biologicals - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Pharmaceutical and biologicals - Market size and forecast 2023-2028 ($ million)
  • Exhibit 35: Data Table on Pharmaceutical and biologicals - Market size and forecast 2023-2028 ($ million)
  • Exhibit 36: Chart on Pharmaceutical and biologicals - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Pharmaceutical and biologicals - Year-over-year growth 2023-2028 (%)
  • 6.4 Nutritional supplements - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Nutritional supplements - Market size and forecast 2023-2028 ($ million)
  • Exhibit 39: Data Table on Nutritional supplements - Market size and forecast 2023-2028 ($ million)
  • Exhibit 40: Chart on Nutritional supplements - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Nutritional supplements - Year-over-year growth 2023-2028 (%)
  • 6.5 Management system - Market size and forecast 2023-2028
  • Exhibit 42: Chart on Management system - Market size and forecast 2023-2028 ($ million)
  • Exhibit 43: Data Table on Management system - Market size and forecast 2023-2028 ($ million)
  • Exhibit 44: Chart on Management system - Year-over-year growth 2023-2028 (%)
  • Exhibit 45: Data Table on Management system - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by Type
  • Exhibit 46: Market opportunity by Type ($ million)
  • Exhibit 47: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

  • 7.1 Market segments
  • Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
  • Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
  • 7.2 Comparison by End-user
  • Exhibit 50: Chart on Comparison by End-user
  • Exhibit 51: Data Table on Comparison by End-user
  • 7.3 Dairy farm - Market size and forecast 2023-2028
  • Exhibit 52: Chart on Dairy farm - Market size and forecast 2023-2028 ($ million)
  • Exhibit 53: Data Table on Dairy farm - Market size and forecast 2023-2028 ($ million)
  • Exhibit 54: Chart on Dairy farm - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on Dairy farm - Year-over-year growth 2023-2028 (%)
  • 7.4 Veterinary hospitals and clinics - Market size and forecast 2023-2028
  • Exhibit 56: Chart on Veterinary hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 57: Data Table on Veterinary hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 58: Chart on Veterinary hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibit 59: Data Table on Veterinary hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • 7.5 Beef farm - Market size and forecast 2023-2028
  • Exhibit 60: Chart on Beef farm - Market size and forecast 2023-2028 ($ million)
  • Exhibit 61: Data Table on Beef farm - Market size and forecast 2023-2028 ($ million)
  • Exhibit 62: Chart on Beef farm - Year-over-year growth 2023-2028 (%)
  • Exhibit 63: Data Table on Beef farm - Year-over-year growth 2023-2028 (%)
  • 7.6 Market opportunity by End-user
  • Exhibit 64: Market opportunity by End-user ($ million)
  • Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 69: Chart on Geographic comparison
  • Exhibit 70: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Germany - Market size and forecast 2023-2028
  • Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.9 UK - Market size and forecast 2023-2028
  • Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.10 China - Market size and forecast 2023-2028
  • Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.11 France - Market size and forecast 2023-2028
  • Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ million)
  • Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 107: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 112: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 113: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification
  • 12.3 Advanced Animal Diagnostics
  • Exhibit 115: Advanced Animal Diagnostics - Overview
  • Exhibit 116: Advanced Animal Diagnostics - Product / Service
  • Exhibit 117: Advanced Animal Diagnostics - Key offerings
  • 12.4 Bio-Vet
  • Exhibit 118: Bio-Vet - Overview
  • Exhibit 119: Bio-Vet - Product / Service
  • Exhibit 120: Bio-Vet - Key offerings
  • 12.5 Boehringer Ingelheim International GmbH
  • Exhibit 121: Boehringer Ingelheim International GmbH - Overview
  • Exhibit 122: Boehringer Ingelheim International GmbH - Business segments
  • Exhibit 123: Boehringer Ingelheim International GmbH - Key news
  • Exhibit 124: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibit 125: Boehringer Ingelheim International GmbH - Segment focus
  • 12.6 Ceva Sante Animale
  • Exhibit 126: Ceva Sante Animale - Overview
  • Exhibit 127: Ceva Sante Animale - Product / Service
  • Exhibit 128: Ceva Sante Animale - Key offerings
  • 12.7 Elanco Animal Health Inc.
  • Exhibit 129: Elanco Animal Health Inc. - Overview
  • Exhibit 130: Elanco Animal Health Inc. - Product / Service
  • Exhibit 131: Elanco Animal Health Inc. - Key offerings
  • 12.8 Endovac Animal Health
  • Exhibit 132: Endovac Animal Health - Overview
  • Exhibit 133: Endovac Animal Health - Product / Service
  • Exhibit 134: Endovac Animal Health - Key offerings
  • 12.9 HIPRA S A
  • Exhibit 135: HIPRA S A - Overview
  • Exhibit 136: HIPRA S A - Product / Service
  • Exhibit 137: HIPRA S A - Key offerings
  • 12.10 ImmuCell Corp.
  • Exhibit 138: ImmuCell Corp. - Overview
  • Exhibit 139: ImmuCell Corp. - Business segments
  • Exhibit 140: ImmuCell Corp. - Key offerings
  • Exhibit 141: ImmuCell Corp. - Segment focus
  • 12.11 Merck KGaA
  • Exhibit 142: Merck KGaA - Overview
  • Exhibit 143: Merck KGaA - Business segments
  • Exhibit 144: Merck KGaA - Key news
  • Exhibit 145: Merck KGaA - Key offerings
  • Exhibit 146: Merck KGaA - Segment focus
  • 12.12 Nimrod Veterinary Products Ltd.
  • Exhibit 147: Nimrod Veterinary Products Ltd. - Overview
  • Exhibit 148: Nimrod Veterinary Products Ltd. - Product / Service
  • Exhibit 149: Nimrod Veterinary Products Ltd. - Key offerings
  • 12.13 Norbrook Laboratories Ltd.
  • Exhibit 150: Norbrook Laboratories Ltd. - Overview
  • Exhibit 151: Norbrook Laboratories Ltd. - Product / Service
  • Exhibit 152: Norbrook Laboratories Ltd. - Key offerings
  • 12.14 Thermo Fisher Scientific Inc.
  • Exhibit 153: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 154: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 155: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 156: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 157: Thermo Fisher Scientific Inc. - Segment focus
  • 12.15 Vetoquinol SA
  • Exhibit 158: Vetoquinol SA - Overview
  • Exhibit 159: Vetoquinol SA - Business segments
  • Exhibit 160: Vetoquinol SA - Key news
  • Exhibit 161: Vetoquinol SA - Key offerings
  • Exhibit 162: Vetoquinol SA - Segment focus
  • 12.16 Virbac Group
  • Exhibit 163: Virbac Group - Overview
  • Exhibit 164: Virbac Group - Business segments
  • Exhibit 165: Virbac Group - Key news
  • Exhibit 166: Virbac Group - Key offerings
  • Exhibit 167: Virbac Group - Segment focus
  • 12.17 Zoetis Inc.
  • Exhibit 168: Zoetis Inc. - Overview
  • Exhibit 169: Zoetis Inc. - Business segments
  • Exhibit 170: Zoetis Inc. - Key news
  • Exhibit 171: Zoetis Inc. - Key offerings
  • Exhibit 172: Zoetis Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 173: Inclusions checklist
  • Exhibit 174: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 175: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 176: Research methodology
  • Exhibit 177: Validation techniques employed for market sizing
  • Exhibit 178: Information sources
  • 13.5 List of abbreviations
  • Exhibit 179: List of abbreviations